Formula: | C19H24FN3O3 |
Molecular Weight: | 361.42 |
Rotatable Bond Donors: | 7 |
clogP: | 2.60 |
Topological Polar Surface Area: | 63.57 |
Lipinski's RO5: | MW: 361.42 HBA: 6 HBD: 1 RB: 7 LogP: 2.60 |
Rule of Three: | MW: 361.42 HBA: 6 HBD: 1 RB: 7 LogP: 2.60 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS24035 | 0.7 | EOS24035 RDKit 3D 27 30 0 0 0 0 0 0 0 0999 V2000 0.7382 -2.5557 0.2277 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4007 -1.6752 0.0398 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.3383 -0.4101 -0.4962 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8678 0.1809 -1.0355 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9619 0.5957 -2.1888 O 0 0 0 0 0 0 0 0 0 0 0 0 1.9172 0.1960 -0.1436 N 0 0 0 0 0 0 0 0 0 0 0 0 3.1088 0.8997 -0.5215 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1812 0.7249 0.4912 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3087 1.5934 1.5690 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3286 1.4034 2.4918 C 0 0 0 0 0 0 0 0 0 0 0 0 6.1886 0.3374 2.2857 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0981 -0.5233 1.2471 N 0 0 0 0 0 0 0 0 0 0 0 0 5.0957 -0.3056 0.3719 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6374 0.0891 -0.4977 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0597 1.3633 -0.8771 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.4245 1.6788 -1.1954 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3689 3.0398 -1.8477 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1079 3.6751 -1.2980 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2773 2.5160 -0.8139 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1419 2.6574 -0.3825 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5008 -0.9745 -0.0630 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8946 -1.1002 0.1079 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.4129 -2.2991 0.5963 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7390 -2.4205 0.7511 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.5902 -3.3653 0.9273 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2072 -3.2644 0.7797 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6934 -2.0568 0.2857 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 6 7 1 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 3 14 2 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 14 21 1 0 21 22 2 0 22 23 1 0 23 24 1 0 23 25 2 0 25 26 1 0 26 27 2 0 27 2 1 0 13 8 1 0 19 15 1 0 27 21 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |